MicroProtein Technologies Inc. (MPT) is a pioneer in the field of biotechnology, offering Microbial / E.coli CDMO , CRO and CMO services using MPTxpress, a unique solid-state/liquid-free and stress-free E.coli manufacturing platform; and commercializing recombinant proteins and other antibody affinity proteins. Using our patented MPTxpress technology, we aim to lead the industry in the production of microbially-expressed recombinant proteins, antibody fragments, enzymes and plasmid DNA for use in biopharmaceuticals for clinical / commercial use, diagnostics, reagents, veterinary medicine, non-clinical, academic and industrial applications.

Read more about our novel upstream and fermentation process in our feature in BioProcess International here and in Genetic Engineering Biotechnology News here